{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T16:29:12Z","timestamp":1770136152300,"version":"3.49.0"},"reference-count":84,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100005725","name":"CHDI Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Neurology"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1016\/j.expneurol.2016.09.007","type":"journal-article","created":{"date-parts":[[2016,9,17]],"date-time":"2016-09-17T21:18:25Z","timestamp":1474147105000},"page":"69-82","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Progressive gene dose-dependent disruption of the methamphetamine-sensitive circadian oscillator-driven rhythms in a knock-in mouse model of Huntington's disease"],"prefix":"10.1016","volume":"286","author":[{"given":"Koliane","family":"Ouk","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juliet","family":"Aungier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. Jennifer","family":"Morton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.expneurol.2016.09.007_bb0005","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1093\/brain\/122.12.2353","article-title":"Huntington's disease progression. PET and clinical observations","volume":"122","author":"Andrews","year":"1999","journal-title":"Brain"},{"key":"10.1016\/j.expneurol.2016.09.007_bb0010","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1093\/brain\/119.6.2085","article-title":"Striatal glucose metabolism and dopamine D2 receptor binding in asymptomatic gene carriers and patients with Huntington's disease","volume":"119","author":"Antonini","year":"1996","journal-title":"Brain"},{"key":"10.1016\/j.expneurol.2016.09.007_bb0015","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1001\/archneur.65.4.482","article-title":"Rapid eye movement sleep disturbances in Huntington disease","volume":"65","author":"Arnulf","year":"2008","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.expneurol.2016.09.007_bb0020","first-page":"2326","article-title":"Human circadian rhythms: a multioscillatory system","volume":"35","author":"Aschoff","year":"1976","journal-title":"Fed. Proc."},{"key":"10.1016\/j.expneurol.2016.09.007_bb0025","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/1467-9450.00238","article-title":"Dopamine and cognitive functioning: Brain imaging findings in Huntington's disease and normal aging","volume":"42","author":"B\u00e4ckman","year":"2001","journal-title":"Scand. J. Psychol."},{"key":"10.1016\/j.expneurol.2016.09.007_bb0030","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1093\/brain\/120.12.2207","article-title":"Cognitive deficits in Huntington's disease are predicted by dopaminergic PET markers and brain volumes","volume":"120","author":"B\u00e4ckman","year":"1997","journal-title":"Brain"},{"key":"10.1016\/j.expneurol.2016.09.007_bb0035","doi-asserted-by":"crossref","first-page":"15005","DOI":"10.1038\/nrdp.2015.5","article-title":"Huntington disease","volume":"1","author":"Bates","year":"2015","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.expneurol.2016.09.007_bb0040","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1600-0447.2007.01058.x","article-title":"Dopamine dysregulation syndrome: implications for a dopamine hypothesis of bipolar disorder","volume":"116","author":"Berk","year":"2007","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.expneurol.2016.09.007_bb0045","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/0022-510X(73)90175-5","article-title":"Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations","volume":"20","author":"Bernheimer","year":"1973","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.expneurol.2016.09.007_bb0050","doi-asserted-by":"crossref","unstructured":"Blum, I.D., Zhu, L., Moquin, L., Kokoeva, M. V, Gratton, A., Giros, B., Storch, K.-F., 2014. A highly tunable dopaminergic oscillator generates ultradian rhythms of behavioral arousal. Elife 3, e05105.","DOI":"10.7554\/eLife.05105"},{"key":"10.1016\/j.expneurol.2016.09.007_bb0055","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1097\/00002826-200207000-00002","article-title":"Biologic rhythms and Parkinson's disease: a chronopharmacologic approach to considering fluctuations in function","volume":"25","author":"Bruguerolle","year":"2002","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/j.expneurol.2016.09.007_bb0060","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1002\/9780470942390.mo110217","article-title":"Health evaluation of experimental laboratory mice","volume":"2","author":"Burkholder","year":"2012","journal-title":"Curr. Protoc. Mouse Biol."},{"key":"10.1016\/j.expneurol.2016.09.007_bb0065","doi-asserted-by":"crossref","first-page":"3727","DOI":"10.1113\/JP270268","article-title":"Relationship between subthalamic nucleus neuronal activity and electrocorticogram is altered in the R6\/2 mouse model of Huntington's disease","volume":"16","author":"Callahan","year":"2015","journal-title":"J. Physiol."},{"key":"10.1016\/j.expneurol.2016.09.007_bb0070","doi-asserted-by":"crossref","first-page":"3248","DOI":"10.1523\/JNEUROSCI.19-08-03248.1999","article-title":"Characterization of progressive motor deficits in mice transgenic for the human Huntington's disease mutation","volume":"19","author":"Carter","year":"1999","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2016.09.007_bb0075","doi-asserted-by":"crossref","first-page":"6480","DOI":"10.1073\/pnas.95.11.6480","article-title":"Altered brain neurotransmitter receptors in transgenic mice expressing a portion of an abnormal human Huntington disease gene","volume":"95","author":"Cha","year":"1998","journal-title":"PNAS"},{"key":"10.1016\/j.expneurol.2016.09.007_bb0080","doi-asserted-by":"crossref","first-page":"114","DOI":"10.3389\/fnins.2013.00114","article-title":"Dopamine imbalance in Huntington's disease: a mechanism for the lack of behavioral flexibility","volume":"7","author":"Chen","year":"2013","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.expneurol.2016.09.007_bb0085","doi-asserted-by":"crossref","first-page":"4993","DOI":"10.1523\/JNEUROSCI.0135-16.2016","article-title":"Compromised dopaminergic encoding of reward accompanying suppressed willingness to overcome high effort costs is a prominent prodromal characteristic of the Q175 mouse model of Huntington's disease","volume":"36","author":"Covey","year":"2016","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2016.09.007_bb0090","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.nbd.2011.07.016","article-title":"The methamphetamine-sensitive circadian oscillator is dysfunctional in a transgenic mouse model of Huntington's disease","volume":"45","author":"Cuesta","year":"2012","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.expneurol.2016.09.007_bb0095","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.nbd.2013.11.008","article-title":"Behavioral therapy reverses circadian deficits in a transgenic mouse model of Huntington's disease","volume":"63","author":"Cuesta","year":"2014","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.expneurol.2016.09.007_bb0100","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1093\/brain\/awt132","article-title":"Longitudinal analysis of the electroencephalogram and sleep phenotype in the R6\/2 mouse model of Huntington's disease","volume":"136","author":"Fisher","year":"2013","journal-title":"Brain"},{"key":"10.1016\/j.expneurol.2016.09.007_bb0105","doi-asserted-by":"crossref","first-page":"379","DOI":"10.5665\/sleep.5448","article-title":"Quantitative electroencephalographic analysis provides an early-stage indicator of disease onset and progression in the zQ175 knock-in mouse model of Huntington's disease","volume":"39","author":"Fisher","year":"2016","journal-title":"Sleep"},{"key":"10.1016\/j.expneurol.2016.09.007_bb0110","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1093\/brain\/120.3.503","article-title":"PET study of the pre- and post-synaptic dopaminergic markers for the neurodegenerative process in Huntington's disease","volume":"120","author":"Ginovart","year":"1997","journal-title":"Brain"},{"key":"10.1016\/j.expneurol.2016.09.007_bb0115","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0306-4522(00)00008-7","article-title":"The pattern of neurodegeneration in Huntington's disease: a comparative study of cannabinoid, dopamine, adenosine, and GABAA receptor alterations in the human basal ganglia in Huntington's disease","volume":"97","author":"Glass","year":"2000","journal-title":"Neuroscience"},{"key":"10.1016\/j.expneurol.2016.09.007_bb0120","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1002\/mds.25159","article-title":"Striatal neuronal loss correlates with clinical motor impairment in Huntington's disease","volume":"27","author":"Guo","year":"2012","journal-title":"Mov. Disord."},{"key":"10.1016\/j.expneurol.2016.09.007_bb0125","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1176\/appi.ajp.2008.08010098","article-title":"Sleep and circadian rhythms in bipolar disorder: seeking synchrony, harmony, and regulation","volume":"165","author":"Harvey","year":"2008","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.expneurol.2016.09.007_bb0130","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.smrv.2011.03.004","article-title":"Circadian rhythms, sleep, and substance abuse","volume":"16","author":"Hasler","year":"2012","journal-title":"Sleep Med. Rev."},{"key":"10.1016\/j.expneurol.2016.09.007_bb0135","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1046\/j.1471-4159.2002.00804.x","article-title":"The role of dopamine in motor symptoms in the R6\/2 transgenic mouse model of Huntington's disease","volume":"81","author":"Hickey","year":"2002","journal-title":"J. Neurochem."},{"key":"10.1016\/j.expneurol.2016.09.007_bb0140","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/0031-9384(86)90265-9","article-title":"Disorganization of the rat activity rhythm by chronic treatment with methamphetamine","volume":"38","author":"Honma","year":"1986","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.expneurol.2016.09.007_bb0145","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/0031-9384(87)90281-2","article-title":"Activity rhythms in the circadian domain appear in suprachiasmatic nuclei lesioned rats given methamphetamine","volume":"40","author":"Honma","year":"1987","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.expneurol.2016.09.007_bb0150","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/0031-9384(88)90146-1","article-title":"Rhythms in behaviors, body temperature and plasma corticosterone in SCN lesioned rats given methamphetamine","volume":"44","author":"Honma","year":"1988","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.expneurol.2016.09.007_bb0155","doi-asserted-by":"crossref","first-page":"2953","DOI":"10.1152\/jn.01056.2014","article-title":"Altered excitatory and inhibitory inputs to striatal medium-sized spiny neurons and cortical pyramidal neurons in the Q175 mouse model of Huntington's disease","volume":"113","author":"Indersmitten","year":"2015","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.expneurol.2016.09.007_bb0160","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/j.conb.2013.03.008","article-title":"Sleep and circadian rhythm disruption in neuropsychiatric illness","volume":"23","author":"Jagannath","year":"2013","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.expneurol.2016.09.007_bb0165","doi-asserted-by":"crossref","unstructured":"Jeantet, Y., Cayzac, S., Cho, Y.H., 2013. \u03b2 Oscillation during slow wave sleep and rapid eye movement sleep in the electroencephalogram of a transgenic mouse model of huntington's disease. PLoS One 8, e79509.","DOI":"10.1371\/journal.pone.0079509"},{"key":"10.1016\/j.expneurol.2016.09.007_bb0170","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1111\/j.1471-4159.2006.03762.x","article-title":"Dopamine release is severely compromised in the R6\/2 mouse model of Huntington's disease","volume":"97","author":"Johnson","year":"2006","journal-title":"J. Neurochem."},{"key":"10.1016\/j.expneurol.2016.09.007_bb0175","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1093\/brain\/awt128","article-title":"Progressive sleep and electroencephalogram changes in mice carrying the Huntington's disease mutation","volume":"136","author":"Kantor","year":"2013","journal-title":"Brain"},{"key":"10.1016\/j.expneurol.2016.09.007_bb0180","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.neuropharm.2016.01.027","article-title":"A single dose of hypnotic corrects sleep and EEG abnormalities in symptomatic Huntington's disease mice","volume":"105","author":"Kantor","year":"2016","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.expneurol.2016.09.007_bb0185","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1007\/s00213-008-1423-1","article-title":"Methamphetamine self-administration by humans subjected to abrupt shift and sleep schedule changes","volume":"203","author":"Kirkpatrick","year":"2009","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.expneurol.2016.09.007_bb0190","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1002\/ana.410220318","article-title":"Elevated serotonin and reduced dopamine in subregionally divided Huntington's disease striatum","volume":"22","author":"Kish","year":"1987","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2016.09.007_bb0195","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.neuropharm.2011.08.020","article-title":"Circadian rhythms and depression: human psychopathology and animal models","volume":"62","author":"Kronfeld-schor","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.expneurol.2016.09.007_bb0200","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.expneurol.2010.12.011","article-title":"Dysfunctions in circadian behavior and physiology in mouse models of Huntington's disease","volume":"228","author":"Kudo","year":"2011","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2016.09.007_bb0205","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1002\/ana.24495","article-title":"Sleep deficits but no metabolic deficits in premanifest Huntington's disease","volume":"78","author":"Lazar","year":"2015","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2016.09.007_bb0210","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0126972","article-title":"Sleep physiology alterations precede plethoric phenotypic changes in R6\/1 Huntington's disease mice","volume":"10","author":"Lebreton","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.expneurol.2016.09.007_bb0215","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0069993","article-title":"The Q175 mouse model of Huntington's disease shows gene dosage- and age-related decline in circadian rhythms of activity and sleep","volume":"8","author":"Loh","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.expneurol.2016.09.007_bb0220","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0092-8674(00)81369-0","article-title":"Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice","volume":"87","author":"Mangiarini","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.expneurol.2016.09.007_bb0225","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.neuropharm.2015.01.013","article-title":"Prior methamphetamine self-administration attenuates the dopaminergic deficits caused by a subsequent methamphetamine exposure","volume":"93","author":"McFadden","year":"2015","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.expneurol.2016.09.007_bb0230","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1017\/S1092852900017260","article-title":"Sleep disorders associated with Parkinson's disease: role of dopamine, epidemiology, and clinical scales of assessment","volume":"13","author":"Mehta","year":"2008","journal-title":"CNS Spectr."},{"key":"10.1016\/j.expneurol.2016.09.007_bb0235","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1602\/neurorx.2.3.465","article-title":"Knock-in mouse models of Huntington's disease","volume":"2","author":"Menalled","year":"2005","journal-title":"NeuroRx"},{"key":"10.1016\/j.expneurol.2016.09.007_bb0240","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.nbd.2009.05.007","article-title":"Systematic behavioral evaluation of Huntington's disease transgenic and knock-in mouse models","volume":"35","author":"Menalled","year":"2009","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.expneurol.2016.09.007_bb0245","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0049838","article-title":"Comprehensive behavioral and molecular characterization of a new knock-in mouse model of Huntington's disease: zQ175","volume":"7","author":"Menalled","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.expneurol.2016.09.007_bb0250","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1113\/jphysiol.1974.sp010623","article-title":"The circadian rhythms of human subjects without timepieces or indication of the alternation of day and night","volume":"240","author":"Mills","year":"1974","journal-title":"J. Physiol."},{"key":"10.1016\/j.expneurol.2016.09.007_bb0255","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0018336","article-title":"Altered dopamine and serotonin metabolism in motorically asymptomatic R6\/2 mice","volume":"6","author":"Mochel","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.expneurol.2016.09.007_bb0260","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.expneurol.2012.10.014","article-title":"Circadian and sleep disorder in Huntington's disease","volume":"243","author":"Morton","year":"2013","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2016.09.007_bb0265","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1523\/JNEUROSCI.3842-04.2005","article-title":"Disintegration of the sleep-wake cycle and circadian timing in Huntington's disease","volume":"25","author":"Morton","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2016.09.007_bb0270","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1111\/j.1471-4159.2009.06501.x","article-title":"Dysregulation of intracellular dopamine stores revealed in the R6\/2 mouse striatum","volume":"112","author":"Ortiz","year":"2010","journal-title":"J. Neurochem."},{"key":"10.1016\/j.expneurol.2016.09.007_bb0275","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.brainres.2009.03.072","article-title":"Management of sleep\/wake cycles improves cognitive function in a transgenic mouse model of Huntington's disease","volume":"1279","author":"Pallier","year":"2009","journal-title":"Brain Res."},{"key":"10.1016\/j.expneurol.2016.09.007_bb0280","first-page":"7869","article-title":"Pharmacological imposition of sleep slows cognitive decline and reverses dysregulation of circadian gene expression in a transgenic mouse model of Huntington's disease","volume":"27","author":"Pallier","year":"2007","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.expneurol.2016.09.007_bb0285","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.5665\/sleep.4996","article-title":"Polysomnographic findings and clinical correlates in Huntington disease: a cross-sectional cohort study","volume":"38","author":"Piano","year":"2015","journal-title":"Sleep"},{"key":"10.1016\/j.expneurol.2016.09.007_bb0290","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1093\/hmg\/dds037","article-title":"Marked differences in neurochemistry and aggregates despite similar behavioural and neuropathological features of Huntington disease in the full-length BACHD and YAC128 mice","volume":"21","author":"Pouladi","year":"2012","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.expneurol.2016.09.007_bb0295","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.neuroscience.2015.10.039","article-title":"Pathological gamma oscillations, impaired dopamine release, synapse loss and reduced dynamic range of unitary glutamatergic synaptic transmission in the striatum of hypokinetic Q175 Huntington mice","volume":"311","author":"Rothe","year":"2015","journal-title":"Neuroscience"},{"key":"10.1016\/j.expneurol.2016.09.007_bb0300","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1076\/brhm.30.2.178.1422","article-title":"The Lomb-Scargle periodogram in biological rhythm research: analysis of incomplete and unequally spaced time-series","volume":"30","author":"Ruf","year":"1999","journal-title":"Biol. Rhythm. Res."},{"key":"10.1016\/j.expneurol.2016.09.007_bb0305","doi-asserted-by":"crossref","first-page":"4510","DOI":"10.1093\/hmg\/ddu166","article-title":"Progressive axonal transport and synaptic protein changes correlate with behavioral and neuropathological abnormalities in the heterozygous Q175 KI mouse model of Huntington's disease","volume":"23","author":"Smith","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.expneurol.2016.09.007_bb0310","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1093\/brain\/awg077","article-title":"Homozygosity for CAG mutation in Huntington disease is associated with a more severe clinical course","volume":"126","author":"Squitieri","year":"2003","journal-title":"Brain"},{"key":"10.1016\/j.expneurol.2016.09.007_bb0315","doi-asserted-by":"crossref","first-page":"2540","DOI":"10.1111\/jcmm.12604","article-title":"Pridopidine, a dopamine stabilizer, improves motor performance and shows neuroprotective effects in Huntington disease R6\/2 mouse model","volume":"19","author":"Squitieri","year":"2015","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.expneurol.2016.09.007_bb0320","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1002\/syn.1089","article-title":"Vesicular neurotransmitter transporters in Huntington's disease: initial observations and comparison with traditional synaptic markers","volume":"41","author":"Suzuki","year":"2001","journal-title":"Synapse"},{"key":"10.1016\/j.expneurol.2016.09.007_bb0325","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1177\/0748730406287529","article-title":"The methamphetamine-sensitive circadian oscillator (MASCO) in mice","volume":"21","author":"Tataroglu","year":"2006","journal-title":"J. Biol. Rhythm."},{"key":"10.1016\/j.expneurol.2016.09.007_bb0330","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","article-title":"A novel gene containing a trinucleotide that is expanded and unstable on Huntington's disease chromosomes","volume":"72","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.expneurol.2016.09.007_bb0335","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.nbd.2014.11.004","article-title":"Hyperactivation of D1 and A2A receptors contributes to cognitive dysfunction in Huntington's disease","volume":"74","author":"Tyebji","year":"2015","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.expneurol.2016.09.007_bb0340","first-page":"R1957","article-title":"Effects of aging on the circadian rhythm of wheel-running activity in C57BL\/6 mice","volume":"273","author":"Valentinuzzi","year":"1997","journal-title":"Am. J. Phys."},{"key":"10.1016\/j.expneurol.2016.09.007_bb0345","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/0006-8993(83)90217-2","article-title":"Age-related changes in the sleep pattern of male adult rats","volume":"279","author":"Van Gool","year":"1983","journal-title":"Brain Res."},{"key":"10.1016\/j.expneurol.2016.09.007_bb0350","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.expneurol.2012.08.018","article-title":"Circadian and sleep disorders in Parkinson's disease","volume":"243","author":"Videnovic","year":"2013","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2016.09.007_bb0355","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1038\/nrneurol.2014.206","article-title":"\u201cThe clocks that time us\u201d\u2014circadian rhythms in neurodegenerative disorders","volume":"10","author":"Videnovic","year":"2014","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.expneurol.2016.09.007_bb0360","first-page":"2809","article-title":"Circadian rhythm disturbances in manic-depressive illness","volume":"42","author":"Wehr","year":"1983","journal-title":"Fed. Proc."},{"key":"10.1016\/j.expneurol.2016.09.007_bb0365","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1081\/CBI-100101048","article-title":"Age-dependent changes of the circadian system","volume":"17","author":"Weinert","year":"2000","journal-title":"Chronobiol. Int."},{"key":"10.1016\/j.expneurol.2016.09.007_bb0370","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.arr.2009.07.003","article-title":"Circadian temperature variation and ageing","volume":"9","author":"Weinert","year":"2010","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.expneurol.2016.09.007_bb0375","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.physbeh.2006.09.003","article-title":"The circadian rhythm of core temperature: effects of physical activity and aging","volume":"90","author":"Weinert","year":"2007","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.expneurol.2016.09.007_bb0380","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/BF00582342","article-title":"Influence of physical workload on freerunning circadian rhythms of man","volume":"126","author":"Wever","year":"1979","journal-title":"Pl\u00fcgers Arch."},{"key":"10.1016\/j.expneurol.2016.09.007_bb0385","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1093\/sleep\/10.1.57","article-title":"The non-entrained life of a young gentleman at Oxford","volume":"10","author":"Wirz-Justice","year":"1987","journal-title":"Sleep"},{"key":"10.1016\/j.expneurol.2016.09.007_bb0390","doi-asserted-by":"crossref","first-page":"103","DOI":"10.3109\/07420529409055896","article-title":"The effect of old age on the free-running period of circadian rhythms in rat","volume":"11","author":"Witting","year":"1994","journal-title":"Chronobiol. Int."},{"key":"10.1016\/j.expneurol.2016.09.007_bb0395","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0055036","article-title":"Adaptation to experimental jet-lag in R6\/2 mice despite circadian dysrhythmia","volume":"8","author":"Wood","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.expneurol.2016.09.007_bb0400","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.gde.2009.03.007","article-title":"Sleep and circadian rhythm disturbances: Multiple genes and multiple phenotypes","volume":"19","author":"Wulff","year":"2009","journal-title":"Curr. Opin. Genet. Dev."},{"key":"10.1016\/j.expneurol.2016.09.007_bb0405","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/nrn2868","article-title":"Sleep and circadian rhythm disruption in psychiatric and neurodegenerative disease","volume":"11","author":"Wulff","year":"2010","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.expneurol.2016.09.007_bb0410","first-page":"308","article-title":"Sleep and circadian rhythm disruption in schizophrenia","volume":"200","author":"Wulff","year":"2012","journal-title":"BJPsych"},{"key":"10.1016\/j.expneurol.2016.09.007_bb0415","doi-asserted-by":"crossref","first-page":"10801","DOI":"10.1073\/pnas.152318499","article-title":"Effects of aging on central and peripheral mammalian clocks","volume":"99","author":"Yamazaki","year":"2002","journal-title":"PNAS"},{"key":"10.1016\/j.expneurol.2016.09.007_bb0420","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.molbrainres.2003.08.009","article-title":"Analysis of cellular , transgenic and human models of Huntington's disease reveals tyrosine hydroxylase alterations and substantia nigra neuropathology","volume":"119","author":"Yohrling","year":"2003","journal-title":"Mol. Brain Res."}],"container-title":["Experimental Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488616302758?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488616302758?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,4,3]],"date-time":"2021-04-03T14:55:21Z","timestamp":1617461721000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014488616302758"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":84,"alternative-id":["S0014488616302758"],"URL":"https:\/\/doi.org\/10.1016\/j.expneurol.2016.09.007","relation":{},"ISSN":["0014-4886"],"issn-type":[{"value":"0014-4886","type":"print"}],"subject":[],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Progressive gene dose-dependent disruption of the methamphetamine-sensitive circadian oscillator-driven rhythms in a knock-in mouse model of Huntington's disease","name":"articletitle","label":"Article Title"},{"value":"Experimental Neurology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.expneurol.2016.09.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}